The Relation of High Sensitivity C Reactive Protein and Total Leucocytic Count Levels in Threatened Abortion
NCT ID: NCT05986357
Last Updated: 2023-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
240 participants
OBSERVATIONAL
2023-07-30
2023-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research of Serum Procalcitonin, ESR, CRP And Leukocyte Levels in Fertile Missed Abortion Cases
NCT03767179
Covid 19 Vaccine Acceptance in Egyptian Pregnant Women
NCT05258760
Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion
NCT02694198
Biochemical, 2D and 3D Ultrasonographic Predictors of Pregnancy Outcome in Women With Threatened Abortion
NCT06797557
Pregnancy Outcome in Woman With Threatened Abortion
NCT02686112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Study group: had 120 healthy women presenting with threatened miscarriage.
* Control group: had 120 healthy women with an uncomplicated single pregnancy. informed permission will be obtained. All cases subjected to the following: taking complete history, General examination, Special investigations including Obstetric ultrasonography for assessment of gestational age, and exclusion of congenital anomalies or multi-fetal gestation. Laboratory investigations including Estimation of the complete blood picture (CBC), Highly sensitive CRP (HS-CRP) single measurement, Women over 1st trimester abdominal ultrasonographic examination (6-13weeks) using Toshiba with transabdominal transducer probe frequency of 7 MHz to evaluate the following data: Measuring of the fetal crown-rump length (CRL) done to confirm the fetal gestational age and the viability of the fetus. Gestational age will be calculated from the beginning of the last regular menstrual cycle. Women who had hormone therapy or progesterone supplements, as well as pregnancies with a discrepancy between LMP and crown rump length of more than three days, were excluded from the research.
Pregnant women will be under close follow up every 2 weeks by: Obstetric U/S, Measure blood pressure and inform us if severe bleeding occurs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
120 healthy women presenting with threatened miscarriage.
maternal serum C reactive protein
maternal serum high sensitivity C reactive protein
total leucocytic count levels
total leucocytic count levels
differential leucocytic count levels
differential leucocytic count levels
Control group
120 healthy women with an uncomplicated single pregnancy.
maternal serum C reactive protein
maternal serum high sensitivity C reactive protein
total leucocytic count levels
total leucocytic count levels
differential leucocytic count levels
differential leucocytic count levels
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
maternal serum C reactive protein
maternal serum high sensitivity C reactive protein
total leucocytic count levels
total leucocytic count levels
differential leucocytic count levels
differential leucocytic count levels
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* an ultrasound showing an intrauterine gestational sac with a live fetus and a regular fetal heartbeat, with/without a sub-chorionic hematoma,
* healthy women who come for routine antenatal care with spontaneous pregnancy.
Exclusion Criteria
* smoking
* multiple pregnancies
* endocrinological diseases
* history of repeated spontaneous abortions.
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beni-Suef University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sara Abdallah Mohamed Salem
principle investigator/Lecturer of Gynecology and obstetrics Faculty of medicine Beni-Suef University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C reactive protein abortion
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.